Budesonide MMX Add-on to 5-Aminosalicylic Acid Therapy in Mild-to-Moderate Ulcerative Colitis: A Favourable Risk-Benefit Profile
Articolo
Data di Pubblicazione:
2017
Citazione:
Budesonide MMX Add-on to 5-Aminosalicylic Acid Therapy in Mild-to-Moderate Ulcerative Colitis: A Favourable Risk-Benefit Profile / Danese, S; Bonovas, S; Peyrin-Biroulet, L. - In: JOURNAL OF CROHN'S AND COLITIS. - ISSN 1873-9946. - 11:7(2017), pp. 767-768. [10.1093/ecco-jcc/jjx025]
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Danese, S; Bonovas, S; Peyrin-Biroulet, L
Link alla scheda completa:
Pubblicato in: